Literature DB >> 32759991

Identification of epigenetic interactions between microRNA and DNA methylation associated with polycystic ovarian syndrome.

Zhanrui Mao1, Ting Li2, Hui Zhao1, Yulan Qin1, Xuesong Wang2, Yani Kang3.   

Abstract

Aberration in microRNA expression or DNA methylation is a causal factor for polycystic ovarian syndrome. However, the epigenetic interactions between miRNA and DNA methylation remain unexplored in PCOS. We conducted a novel integrated analysis of RNA-seq, miRNA-seq, and methylated DNA-binding domain sequencing on ovarian granulosa cells to reveal the epigenetic interactions involved in the pathogenesis of PCOS. We identified 830 genes and 30 miRNAs that were expressed differently in PCOS, and seven miRNAs negatively regulated target mRNA expression. 130 miRNAs' promoters were significantly differently methylated, while 13 were associated with miRNA expression. Furthermore, the hypermethylation of miR-429, miR-141-3p, and miR-126-3p' promoter was found related to miRNA expression suppression and therefore their corresponding genes upregulation, including XIAP, BRD3, MAPK14, and SLC7A5. Our findings provide a novel insight in PCOS. The consequential reversal of genes silencing may participate in PCOS pathogenesis and served as potential molecular targets for PCOS.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32759991      PMCID: PMC7782128          DOI: 10.1038/s10038-020-0819-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

Review 1.  Multiomics Analysis-Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome.

Authors:  Shikha Rani; Piyush Chandna
Journal:  Reprod Sci       Date:  2022-01-27       Impact factor: 3.060

2.  Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.

Authors:  Gan Qiao; Jinshan Xing; Xin Luo; Chunxiang Zhang; Jingyan Yi
Journal:  Endocrine       Date:  2022-09-06       Impact factor: 3.925

Review 3.  Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.

Authors:  Giorgia Scarfò; Simona Daniele; Jonathan Fusi; Marco Gesi; Claudia Martini; Ferdinando Franzoni; Vito Cela; Paolo Giovanni Artini
Journal:  Biomedicines       Date:  2022-06-02

Review 4.  Androgen-induced epigenetic modulations in the ovary.

Authors:  Irving Salinas; Niharika Sinha; Aritro Sen
Journal:  J Endocrinol       Date:  2021-06       Impact factor: 4.669

5.  Identification of Three Potential circRNA Biomarkers of Polycystic Ovary Syndrome by Bioinformatics Analysis and Validation.

Authors:  Pengyu Huang; Shengrong Du; Yunhong Lin; Zhiqing Huang; Haiyan Li; Gangxin Chen; Suzhu Chen; Qingfen Chen; Lincui Da; Hang Shi; Wei Wei; Lei Yang; Yan Sun; Beihong Zheng
Journal:  Int J Gen Med       Date:  2021-09-22

6.  Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation.

Authors:  Yulan Qin; Yuhuan Wang; Hui Zhao; Zhaoxia Yang; Yani Kang
Journal:  Ann Transl Med       Date:  2021-09

7.  Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/XIAP axis.

Authors:  Xiaohui Lu; Haijie Gao; Bo Zhu; Guilan Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Characterization of micro-RNA in women with different ovarian reserve.

Authors:  Masood Abu-Halima; Lea Simone Becker; Basim M Ayesh; Simona Lucia Baus; Amer Hamza; Ulrike Fischer; Mohamad Hammadeh; Andreas Keller; Eckart Meese
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

Review 9.  Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence.

Authors:  Régine P M Steegers-Theunissen; Rosalieke E Wiegel; Pauline W Jansen; Joop S E Laven; Kevin D Sinclair
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.